Percentage of estimated specific complication costs among total estimated complication costs in Medicare fee-for-service beneficiaries with type 2 diabetes in 2017. “Others” refers to angina, hypoglycemia, blindness and vision loss, retinopathy intravitreal injections, LEA, chronic retinopathy, ketoacidosis, kidney transplant, and photocoagulation; each complication accounted for <5% of the total.